A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Clinical trial NCT06384807 · RECRUITING
Trial details
- NCT number
- NCT06384807
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2028-02-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.